semaglutide side effects go away 🥇 16 of to Know What Should I Expect During

The most clearly defined groups who may be considered in future include individuals with: Metabolic dysfunction-associated steatotic liver disease (MASLD) particularly those with concurrent obesity, type 2 diabetes, or metabolic syndrome Metabolic dysfunction-associated steatohepatitis (MASH) the progressive inflammatory subtype associated with fibrosis and risk of cirrhosis Obesity with elevated liver enzymes (ALT/AST) where hepatic steatosis has been confirmed on imaging Type 2 diabetes with evidence of hepatic fat accumulation , where current glucose-lowering therapies have not adequately addressed liver disease Patients with significant hepatic fibrosis (stage F2 or above) represent a group with particularly high unmet need, as there are currently no licensed pharmacological treatments specifically approved for MASH in the UK

Intestinal blockages Intestinal obstructions (also called bowel obstructions or blockages) are not listed on Wegovys warning label

& Paganga, G

Warshaw JB, Curry E (1980)

If youre a candidate, well initiate treatment with either semaglutide or tirzepatide and schedule follow-up appointments to monitor your response and make any necessary adjustments